These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2786677

  • 1. Generalized decrease in brain glucose metabolism during fasting in humans studied by PET.
    Redies C, Hoffer LJ, Beil C, Marliss EB, Evans AC, Lariviere F, Marrett S, Meyer E, Diksic M, Gjedde A.
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E805-10. PubMed ID: 2786677
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
    Bolo NR, Brennan KM, Jones RM, Budinger TF.
    Ann N Y Acad Sci; 1987 Jun; 508():451-9. PubMed ID: 3501936
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain.
    Crane PD, Pardridge WM, Braun LD, Oldendorf WH.
    J Neurochem; 1983 Jan; 40(1):160-7. PubMed ID: 6848656
    [Abstract] [Full Text] [Related]

  • 9. 2-Deoxy-2-[18F]fluoro-D-glucose for metabolic studies: current status.
    Fowler JS, Wolf AP.
    Int J Rad Appl Instrum A; 1986 Jan; 37(8):663-8. PubMed ID: 3021667
    [No Abstract] [Full Text] [Related]

  • 10. F-18-labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart.
    Goodman MM, Elmaleh DR, Kearfott KJ, Ackerman RH, Hoop B, Brownell GL, Alpert NM, Strauss HW.
    J Nucl Med; 1981 Feb; 22(2):138-44. PubMed ID: 6970254
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism.
    Kearfott KJ, Elmaleh DR, Goodman M, Correia JA, Alpert NM, Ackerman RH, Brownell GL, Strauss WH.
    Int J Nucl Med Biol; 1984 May; 11(1):15-22. PubMed ID: 6610664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H, Evans AC, Gjedde A.
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [Abstract] [Full Text] [Related]

  • 20. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography.
    Sasaki H, Kanno I, Murakami M, Shishido F, Uemura K.
    J Cereb Blood Flow Metab; 1986 Aug; 6(4):447-54. PubMed ID: 3488323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.